You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
HA-1077 dihydrochloride has been shown to be a vasodilating agent as well as a potent inhibitor of Rock-2 (Rho-associated Kinase II), cGKI (cGMP-dependent protein kinase), PKA (cAMP-dependent protein kinase), MYLK, and CaMKII. Rho kinase signaling pathways are thought to cause invasion, migration, and proliferation of certain cells. Studies have shown this compound can also inhibit myosin light chain kinase in vitro and suppress cell rounding by myosin light chain phosphorylation. Mechanistic experiments report that HA-1077 inhibits vascular smooth muscle contraction by acting as a calcium channel protein inhibitor. HA-1077 dihydrochloride is an inhibitor of MSK1, PKC, PRK2 and Rsk-2.
1. Asano, T., et al. 1987. J. Pharmacol. Exp. Ther. 241: 1033-1040. PMID: 3598899
2. Asano, T., et al. 1989. Br. J. Pharmacol. 98: 1091-1100. PMID: 2611484
3. Sasaki, Y., et al. 1990. Biochem. Biophys. Res. Commun. 171: 1182-1187. PMID: 2222437
4. Nagumo, H., et al. 2000. Am. J. Physiol., Cell Physiol. 278: C57-C65. PMID: 10644512
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.